Virtual patient 'surrogates' can personalize cancer treatments
Scientists have developed mathematical models that act as patient 'surrogates' for evaluating potential prostate cancer treatments.
Feb 15, 2022
0
7
Scientists have developed mathematical models that act as patient 'surrogates' for evaluating potential prostate cancer treatments.
Feb 15, 2022
0
7
Preclinical models that recapitulate aspects of human airway disease are essential for the advancement of novel therapeutics and vaccines. In the current study published in the journal mBIO, researchers at Baylor College ...
Feb 15, 2022
0
131
Immunologists in Australia have eavesdropped on a stowaway population of B cells that hide in the lungs, their telltale biomarkers indicating they're armed to fight influenza—and their presence yet another sign that the ...
Research led by Washington State University scientists supports a novel theory that the innate immune system people are born with can respond differently to specific pathogens. This quality, known as immunological specificity, ...
Feb 8, 2022
0
59
The concept of new bone formation via divalent cations is widely reported although the underlying mechanism of the process remains unclear. In a new report now published in Nature Communications, Wei Qiao and a team of scientists ...
The first generation of COVID-19 vaccines have been highly effective, but also have limitations: their efficacy can wane without a booster shot, and they may be less effective against some variants. Now scientists at The ...
Feb 1, 2022
0
423
In autoimmunity, the mechanisms that guarantee that our defense system does not attack our own body—tolerance to oneself—does not work properly. Multiple sclerosis, which affects one in every 1,000 people in Spain, is ...
Jan 19, 2022
0
272
A study conducted in two rural Massachusetts jails found that people with opioid use disorder who were incarcerated and received a medication approved to treat opioid use disorder, known as buprenorphine, were less likely ...
Jan 18, 2022
0
12
Cell cultures and animal studies show that TriSb92, a new molecule developed by the researchers, protects against coronavirus infection for at least eight hours even in cases of high exposure risk. In contrast to vaccine ...
Jan 10, 2022
0
19
Scientists led by Dr. Andrés Hidalgo at the Centro Nacional de Investigadores Cardiovasculares (CNIC) have discovered that the immune system's circulating neutrophils acquire different behavior patterns during inflammatory ...
Jan 5, 2022
0
85